
When: Thursday, December 16, 2021 @ 1:00 PM Eastern
Join Jason Ausili, Pharm.D. for a panel discussion with special guests Donald Klepser, Ph.D. from the University of Nebraska Medical Center and Griff Danheim from leading diagnostic healthcare manufacturer Quidel. The topic will be milestone COVID-19 Test & Treat programs and how they will impact community pharmacies, both now and in the future.
During this webinar, you will:
- Listen to expert opinions on the scope of COVID-19 Test & Treat programs
- Learn how new oral antiviral medication fits into the Test & Treat strategy
- Discover what role Test & Treat will play in your pharmacy beyond the COVID-19 pandemic
- Explore step-by-step how to become a Test & Treat pharmacy
About the Speaker:
![]() | Jason Ausili, Pharm.D. is the Chief Clinical Officer for FDS Amplicare, now part of EnlivenHealth™. He is an experienced pharmacy leader with demonstrated skill in retail pharmacy management, pharmacy operations, pharmacy benefit management, healthcare information technology (HIT), and more. Jason is a former member of the Pharmacy Quality Alliance Board of Directors as well as the former Director of Pharmacy Affairs for the National Association of Chain Drug Stores (NACDS). |
Special Guests:
![]() Donald Klepser, PhD, MBA Associate Dean for Academic Affairs University of Nebraska Medical Center | ![]() Griff Danheim New Markets Sales Director Quidel |